首页> 外文期刊>Stem cells international >“Humanized” Stem Cell Culture Techniques: The Animal Serum Controversy
【24h】

“Humanized” Stem Cell Culture Techniques: The Animal Serum Controversy

机译:“人源化”干细胞培养技术:动物血清学争议

获取原文
           

摘要

Cellular therapy is reaching a pinnacle with an understanding of the potential of human mesenchymal stem cells (hMSCs) to regenerate damaged tissue in the body. The limited numbers of these hMSCs in currently identified sources, like bone marrow, adipose tissue, and so forth, bring forth the need for theirin vitroculture/expansion. However, the extensive usage of supplements containing xenogeneic components in the expansion-media might pose a risk to the post-transplantation safety of patients. This warrants the necessity to identify and develop chemically defined or “humanized” supplements which would makein vitrocultured/processed cells relatively safer for transplantation in regenerative medicine. In this paper, we outline the various caveats associated with conventionally used supplements of xenogenic origin and also portray the possible alternatives/additives which could one day herald the dawn of a new era in the translation ofin vitrocultured cells to therapeutic interventions.
机译:了解人类间充质干细胞(hMSCs)再生体内受损组织的潜力,细胞疗法正达到顶峰。在目前确定的来源中,例如骨髓,脂肪组织等中,这些hMSC数量有限,因此需要对其进行体外培养/扩增。但是,在膨胀培养基中大量使用含有异种成分的补充剂可能会对患者的移植后安全性构成威胁。这保证了鉴定和开发化学定义的或“人源化”的补充剂的必要性,这将使体外培养/加工的细胞相对更安全地用于再生医学中的移植。在本文中,我们概述了与异种来源的常规使用补充剂相关的各种注意事项,并描绘了可能的替代品/添加剂,这些替代品/添加剂有可能预示着将体外培养的细胞转化为治疗性干预的新时代的到来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号